RECRUITING

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Official Title

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Quick Facts

Study Start:2017-11-02
Study Completion:2035-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03413982

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
  2. * Patients can participate in any additional research studies during the patients' participation within this protocol.
  1. * Patients who do not have presumed bladder cancer will not be eligible

Contacts and Locations

Study Contact

Jane Ladesma
CONTACT
913-588-8721
jledesma2@kumc.edu

Principal Investigator

John Taylor, MD
PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center

Study Locations (Sites)

University of Kansas Medical Center
Kansas City, Kansas, 66160
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

  • John Taylor, MD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-11-02
Study Completion Date2035-01-01

Study Record Updates

Study Start Date2017-11-02
Study Completion Date2035-01-01

Terms related to this study

Additional Relevant MeSH Terms

  • Bladder Cancer